Nabriva Therapeutics plc (NASDAQ:NBRV) previous close was $1.40 while the outstanding shares total 26.41M. The firm has a beta of 1.87. NBRV’s shares traded lower
Nabriva Therapeutics plc (NASDAQ:NBRV) Relative Strength Index (RSI) is 46.95, with weekly volatility at 4.58% and ATR at 0.10. The NBRV stock’s 52-week price range
Nabriva Therapeutics plc (NASDAQ:NBRV) shares traded lower over the last trading session, losing -2.19% on 06/04/21. The shares fell to a low of $1.33 before
Nabriva Therapeutics plc (NASDAQ:NBRV) Relative Strength Index (RSI) is 39.27, with weekly volatility at 15.20% and ATR at 0.14. The NBRV stock’s 52-week price range
Nabriva Therapeutics plc (NASDAQ:NBRV) shares traded higher over the last trading session, gaining 2.03% on 05/26/21. The shares fell to a low of $1.49 before
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
© 2024, Fueled by Smart TechOne
